| Volume 33(2025) > Number 4 | Economic evaluation of AI-assisted technologies in healthcare: A systematic review | Wen-Tung Wu, Yi-Wen Chao, Tsung-Kun Lin, Ching-Kuo Huang, Ping-Hsuan Hsieh | 487-500 |
| Volume 33(2025) > Number 4 | ACKNOWLEDGMENT OF REVIEWERS | Editorial Office | 502 |
| Volume 33(2025) > Number 4 | Corrigendum to “Yi-Qi-Xuan-Fei Formula ameliorate chronic obstructive pulmonary disease by remodeling lung and intestinal florase in rat models” | Si-Si Han, Li-Yun Song, Peng-Tao Liang, Yin-Ying Wang, Yi Ying, Li Li, Jia-Li Yuan, Zhong-Shan Yang | 503 |
| Volume 33(2025) > Number 3 | Global research trends on avocado oil and its fatty acid composition: A bibliometric review | Ahmad Kamrullah Aras, Abdul Rohman | 179-192 |
| Volume 33(2025) > Number 3 | In vivo and in vitro perspectives in Parkinson's disease: Mechanisms and the role of phytomedicine | Jeewanjot Singh, Devinder Kumar | 193-212 |
| Volume 33(2025) > Number 3 | Targeted nanosponge-based treatment for pulmonary hypertension: A novel approach | Jashanpreet Kaur, Gursimran Kaur, Chamanpreet Kaur, Sandeep Kumar | 213-223 |
| Volume 33(2025) > Number 3 | The rhythm of decline: Circadian disruption inneurodegeneration | Jeewanjot Singh, Devinder Kumar, Jasleen Kaur, Amanpreet Singh | 224-240 |
| Volume 33(2025) > Number 3 | Precision nanomedicine for anxiety: Challenges, opportunities, and future directions in targeted drug delivery | Sehrabpreet Singh, Amanpreet Singh, Shruti, Shailesh Sharma | 241-251 |
| Volume 33(2025) > Number 3 | Yi-Qi-Xuan-Fei Formula ameliorate chronic obstructive pulmonary disease by remodeling lung and intestinal florase in rat models | Si-Si Han, Li-Yun Song, Peng-Tao Liang, Yin-Ying Wang, Yi Ying, Li Li, Jia-Li Yuan, Zhong-Shan Yang | 252-276 |
| Volume 33(2025) > Number 3 | Repurposing dihydroartemisinin as a novel anticancer agent against colorectal cancer stem cells | Meng-Han Wu, Chieh-Ju Sung, Fan-Lu Kung, Jih-Hwa Guh, Yeu Su, Lih-Ching Hsu | 277-291 |